BDNF and Alzheimer disease: In a 5xFAD AD mouse model, vindeburnol treatment induced neuronal maturation in the LC, restored BDNF levels in the hippocampus, and reduced Aβ deposition throughout the brain [13], suggesting that this treatment influences both the LC itself and its noradrenergic projection sites.